Skip to main content
Clinical Trials/NCT05691569
NCT05691569
Recruiting
N/A

Efficacy of Doll Therapy in the Control of Behavioral and psychologIcal Symptoms of Dementia in Acute Geriatric Inpatients: the AGITATE Study.

Centre Hospitalier Universitaire Vaudois1 site in 1 country92 target enrollmentNovember 15, 2024
ConditionsDementia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia
Sponsor
Centre Hospitalier Universitaire Vaudois
Enrollment
92
Locations
1
Primary Endpoint
behavioural and psychological symptoms of dementia
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers severely reducing their quality of life. BPSD worsen during hospitalization and require the administration of psychotropic drugs that are often insufficient to control the symptoms, and may cause severe adverse events.

The investigators propose the use of empathy dolls in order to reduce BPSD and in particular agitation and aggressiveness in acute geriatric in-patients affected by moderate to severe forms of dementia.

The use of doll therapy in the clinical routine will allow to reduce the use of psychotropic drugs, shorten hospitalization, reduce professional and family caregiver burden improving patients' and families' quality of life.

Registry
clinicaltrials.gov
Start Date
November 15, 2024
End Date
August 30, 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Patrizia D'Amelio

Full professor, head of the geriatric and Geriatric rehabilitation Service

Centre Hospitalier Universitaire Vaudois

Eligibility Criteria

Inclusion Criteria

  • age ≥65 years
  • diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2
  • presence of agitation and/or aggressiveness
  • manual and visual abilities sufficient in order to interact with the doll.

Exclusion Criteria

  • age \<65 years;
  • refuse to participate;
  • mild forms of dementia (CDR\<2);
  • contraindication for DT as experience of mournful or traumatic events related to parental experience;
  • life expectancy lower than 3 months;
  • infectious diseases requiring isolation;
  • negative interaction with the doll,
  • presence of delirium.

Outcomes

Primary Outcomes

behavioural and psychological symptoms of dementia

Time Frame: baseline, discharge (up to one week)

Neuro Psychiatic Inventory (NPI). The NPI total score ranges from 0 to 144, higher scores means more severe and frequent behavioural and psycological symptoms of dementia

agitation and aggressiveness within hospital

Time Frame: baseline and hospital discharge discharge (up to one week)

measured by Pittsburgh Agitation Scale (PAS). the score ranges between 0 to 16 on the PAS the higher score means the higher agitation

agitation and aggressiveness outside hospital

Time Frame: baseline, 1 and 4 weeks after discharge

Cohen Mansfield Inventory scale (CMAI). the score ranges betwen 0 and 203, with higher scores indicating more agitation

Secondary Outcomes

  • patients' quality of life(baseline and 4 weeks after discharge)
  • family caregivers' quality of life(baseline and 4 weeks after discharge)
  • family caregiver burden(baseline and 4 weeks after discharge)
  • professional caregiver burden(baseline and at hospital discharge (up to one week))
  • incidence of delirium(every day during hospital stay (up to one week))

Study Sites (1)

Loading locations...

Similar Trials